Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01575028 · ClinicalTrials.gov registry record · Phase 2

Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies

A Phase 2 study, sponsored by Nationwide Children's Hospital.

Terminated
Registry status
Phase 2
Development phase
3
Enrollment target

NCT01575028 is a Phase 2 study that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01575028, a Phase 2 study, was terminated before completion, sponsored by Nationwide Children's Hospital.

TERMINATED
Registry status
Phase 2
Development phase
3 participants
Enrollment target

Study Summary

This study is a prospective, double-blinded, randomized comparison of 2 patient cohorts. One group of patients will receive a transversus abdominis plane (TAP) block. The second group will receive local anesthetic infiltration injected at the surgical site by the surgeon at the end of surgery for a laparoscopic appendectomy. The purpose of this study is to prospectively compare post-operative pain relief in pediatric patients undergoing laparoscopic appendectomy who have received either a transversus abdominis plane (TAP) block or local anesthetic infiltration by the surgeon for analgesia to compare the most appropriate delivery of effective analgesia. In an effort to improve postoperative analgesia while limiting opioid-related adverse effects, there continues to be an increased use of multimodal techniques in infants and children.

Interventions

  • DRUG Bupivacaine
  • DRUG Ropivacaine

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2012-10
Est. Completion 2014-07
Phase Phase 2

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT01575028

The ClinicalTrials.gov registry entry for NCT01575028 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.

NCT01575028 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01575028 about?

NCT01575028 is a clinical study titled "Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies". This study is a prospective, double-blinded, randomized comparison of 2 patient cohorts. One group of patients will receive a transversus abdominis plane (TAP) block. The second group will receive local anesthetic infiltration injected at the surgical site by the surgeon at the end of surgery for a ...

What is the current status of trial NCT01575028?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2012-10. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01575028?

The interventions under investigation include: Bupivacaine (DRUG), Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT01575028?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.